GNH India clears Kenyan Pharmacy and Poison board audit

The company will export the first shipment of lifesaving drugs to Kenya shortly

GNH India, a global pharmaceutical distributor has cleared the Kenyan Pharmacy and Poisons Board audit thereby clearing the path for it to export scheduled drugs to Kenya. The certification will help GNH India trade freely with Kenya. The company will export the first shipment of lifesaving drugs to Kenya shortly and is looking to establish long-lasting business relations with the country. The country, which has been facing a dearth of many lifesaving drugs in recent times will be benefited by this development.

The Pharmacy and Poisons Board is the Drug Regulatory Authority established under the Pharmacy and Poisons Act, Chapter 244 of the Laws of Kenya, and is responsible for regulating the Practice of Pharmacy and the Manufacture and Trade in drugs and poisons in Kenya.

Commenting on this, Dr Piyush Gupta, Associate Director, GNH India said, " Being certified by The Pharmacy and Poisons Board, Kenya authenticates the measures taken by us for the exports of medicines. It gives us tremendous pleasure to be the first Indian specialised wholesaler to clear the audit by any foreign body, and we look forward to many more opportunities."